Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.

Renal failure - 1 Jan 2016

Xu Fengbo, Liu Huilan, Sun Yi

Abstract excerpt

BACKGROUND: We investigated the relationship between plasminogen activator inhibitor-1 (PAI-1) 4G/5G insertion/deletion polymorphism and prevalence of diabetic nephropathy (DN) in Chinese patients. METHODS: A total of 107 patients with type 2 diabetes were randomly recruited in the study, and 102 healthy subjects were selected as Control. Patients were divided into three groups according to their urinary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diabetic Nephropathies

Share to Genotype

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 26616527
DOI: 10.3109/0886022X.2015.1089464

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.PMID 26616527Read ↗

Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.Semantic proximity Read ↗

Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.Semantic proximity Read ↗

[Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].Semantic proximity Read ↗

4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy.Semantic proximity Read ↗

The association between PAI-1 -675 4G/5G polymorphism and type 2 diabetes mellitus.Semantic proximity Read ↗

PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.Semantic proximity Read ↗

Association of PAI-1 4G/5G Polymorphism with Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Association between plasminogen activator inhibitor-1 4G/5G gene polymorphism and immunoglobulin A nephropathy susceptibility.Semantic proximity Read ↗

Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects.Semantic proximity Read ↗

[Relationship between PAI-1 gene 4G/5G polymorphism and clinical profile of IgA nephropathy].Semantic proximity Read ↗

PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.Semantic proximity Read ↗

Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.